High Potency APIs

As the pharmaceutical industry increasingly focuses on targeted therapies, many drug products contain highly potent active pharmaceutical ingredients (HPAPIs) that require specialist handling and containment throughout development and manufacturing.

At Upperton, we support the development and manufacture of drug products containing highly potent compounds, with capabilities designed to handle materials up to OEB 5.

Our facilities, equipment and operating procedures are engineered to enable the safe handling of potent materials while maintaining product quality and protecting personnel.

Whether incorporated into oral solid dose, nasal, pulmonary or other drug product formats, highly potent compounds can present unique formulation and manufacturing challenges. Our experienced scientists work closely with clients to develop robust formulations and manufacturing processes that support progression from early development through to clinical supply.